ivabradine has been researched along with Tachycardia, Ventricular in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Fu, NK; Ying, S; Zhang, J; Zhang, P | 1 |
Çetin, T; Çınar, T; Çinier, G; Eren, S; Hayıroğlu, Mİ; Keskin, K; Pay, L; Tekkeşin, Aİ; Tezen, O; Yumurtaş, AÇ | 1 |
Aziz, Z; Beaser, AD; Kohli, U; Nayak, HM | 1 |
Mackiewicz, U; Mączewski, M; Marciszek, M; Oknińska, M; Paterek, A | 1 |
Klug, D; Vaksmann, G | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Leitz, P; Weller, J | 1 |
Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ | 1 |
Adler, A; Meir, I; Rosso, R; Viskin, S | 1 |
Brink, PR; Bucchi, A; Cohen, IS; Danilo, P; Plotnikov, AN; Robinson, RB; Rosen, MR; Shlapakova, I | 1 |
1 trial(s) available for ivabradine and Tachycardia, Ventricular
Article | Year |
---|---|
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria | 2014 |
8 other study(ies) available for ivabradine and Tachycardia, Ventricular
Article | Year |
---|---|
Ivabradine in the treatment of non-paroxysmal junctional tachycardia with interference atrioventricular dissociation: A case report.
Topics: Electrocardiography; Heart Block; Heart Rate; Humans; Ivabradine; Tachycardia, Sinus; Tachycardia, Ventricular | 2023 |
Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction.
Topics: Arrhythmias, Cardiac; Heart Failure; Humans; Ivabradine; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2023 |
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy.
Topics: Adolescent; Cardiovascular Agents; Electrocardiography; Exercise Test; Flecainide; Humans; Ivabradine; Male; Nadolol; Phenotype; Sympathectomy; Tachycardia, Ventricular | 2020 |
Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Signaling; Cells, Cultured; Heart Rate; Ivabradine; Male; Metoprolol; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Ventricular Fibrillation | 2020 |
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiovascular Agents; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Ivabradine; Male; Nadolol; Tachycardia, Ventricular; Young Adult | 2018 |
Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ivabradine; Long QT Syndrome; Potassium; Rabbits; Risk Assessment; Sotalol; Tachycardia, Ventricular; Time Factors; Veratridine | 2019 |
Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Benzazepines; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Equipment Design; Equipment Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Prospective Studies; Tachycardia, Sinus; Tachycardia, Ventricular; Treatment Outcome | 2013 |
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade.
Topics: Animals; Benzazepines; Calcium Channels; Cardiac Pacing, Artificial; Cardiovascular Agents; Catheter Ablation; Defibrillators, Implantable; Dogs; Electrophysiology; Ivabradine; Male; Muscle Cells; Rats; Risk Factors; Tachycardia, Ventricular | 2008 |